A Year-Long Clinical Study Compares Self-Adhesive And Conventional Bulk-Fill Composites In Class II Cavities
- byDoctor News Daily Team
- 31 July, 2025
- 0 Comments
- 0 Mins
Egypt: In the realm of dental care, advancements in materials and techniques continually shape the landscape of treatment options available to patients. A recent randomized controlled clinical study conducted over a year has shed light on the comparative efficacy of self-adhesive and conventional bulk-fill composites in treating Class II cavities. The study, published in the Journal of Esthetic and Restorative Dentistry, offers valuable insights into the performance of these two commonly used dental materials.
In the study, the researchers compared the efficacy of self-adhesive and conventional bulk-fill composites in class II restorations over 12 months. They found that both materials met Federation Dentaire Internationale criteria, with the self-adhesive composite demonstrating comparable biological and functional performance to the conventional composite. However, the conventional composite exhibited superior esthetic qualities.
Class II cavities, which occur on the sides of molars and premolars, pose unique challenges for dental restorations due to their location and the forces they endure during chewing. In the study, Mohamed S. Ellithy, Conservative Dentistry Department, Faculty of Dentistry, Alexandria University, Alexandria, Egypt, and colleagues compared the clinical efficacy of self-adhesive bulk-fill Surefil One with a traditional bulk-fill composite in class II restorations.
For this purpose, the researchers included sixty-four direct class II composite restorations. They were categorized into two groups: Group I, control group (n = 32): cavities were restored by Filtek One bulk-fill composite with Scotchbond Universal (SBU) adhesive in self-etch mode, Group II, test group (n = 32): cavities were restored by Surefil One self-adhesive bulk-fill composite.
The follow-up period was one year, during which restoration assessment was done at baseline (BL), six months, and 12 months using Federation Dentaire Internationale (FDI) criteria. Data analysis was performed using nonparametric tests. A comparison of restoration characteristics was performed.
The study led to the following findings:
Filtek One and Surefil One bulk-fill composites revealed clinically acceptable FDI scores over 12-month recalls.
Thirty-two patients (64 restorations) were available for all follow-up visits; 100% of the restorations survived.
For esthetic properties, Filtek One was far better than Surefil One at all time points.
In terms of functional and biological properties, both restorations demonstrated comparable performances.
"Filtek One bulk-fill restorations were superior in terms of surface staining, surface luster, color match, and translucency, but Surefil One restorations performed well and were comparable to Filtek One restorations," the researchers wrote. "However, there is a need for additional advancements and research to obtain better esthetics. Furthermore, there is a need for longitudinal studies with extended follow-up periods to assess the clinical potential of both materials."
Reference:
Ellithy, M. S., Abdelrahman, M. H., & Afifi, R. R. Comparative clinical evaluation between self-adhesive and conventional bulk-fill composites in class II cavities: A 1-year randomized controlled clinical study. Journal of Esthetic and Restorative Dentistry. https://doi.org/10.1111/jerd.13242
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Drug which stops tumors' blood supply could help k...
- 25 October, 2025
Processed fats found in margarines unlikely to aff...
- 25 October, 2025
Dark chocolate milk intake linked to improved spri...
- 25 October, 2025
Night-time bright light exposure may raise heart d...
- 25 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!